Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic.
about
Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Budget impact of everolimus fo ...... at are advanced or metastatic.
@en
Budget impact of everolimus fo ...... at are advanced or metastatic.
@nl
type
label
Budget impact of everolimus fo ...... at are advanced or metastatic.
@en
Budget impact of everolimus fo ...... at are advanced or metastatic.
@nl
prefLabel
Budget impact of everolimus fo ...... at are advanced or metastatic.
@en
Budget impact of everolimus fo ...... at are advanced or metastatic.
@nl
P2093
P2860
P1476
Budget impact of everolimus fo ...... at are advanced or metastatic.
@en
P2093
Beilei Cai
Darya B Rose
Dave Nellesen
Maureen P Neary
P2860
P304
P356
10.1080/13696998.2016.1273228
P407
P577
2016-12-16T00:00:00Z